ADYX Projected Dividend Yield
Adynxx Inc ( OTCBB : ADYX )Adynxx is a clinical stage biopharmaceutical company focused on the development of therapeutics called transcription factor decoys and bringing to market disease-modifying products for the treatment of pain and inflammation. Transcription factor decoys are short strands of DNA that specifically bind to and block the activity of their target transcription factors. Transcription factors are proteins that specifically bind to the regulatory regions of one or more target genes and regulate the expression of those genes. Co. utilized its AYX platform of proprietary transcription factor decoys to identify and develop product candidates designed to modify the course of pain. 15 YEAR PERFORMANCE RESULTS |
ADYX Dividend History Detail ADYX Dividend News ADYX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2019 |
May 21, 2019 |
May 06, 2019 |
Apr 22, 2019 |
May 29, 2019 |
1.0500 |
2019 Total: |
1.0500 |